MV

Manoj Vaish

Active Director Director DIN 08013455
DIN 08013455 First appointment Dec 2017 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2017
Shareholding value •••• Premium profile

About Manoj Vaish

Data last updated:

Manoj Vaish is a Director at Eigen Pharmaceuticals Private Limited (since 2017). The company operates in Trading. Eigen Pharmaceuticals Private Limited reported revenue of ₹11.9 Lakh (FY 2020).

DIN 08013455
Primary Designation Director
Industry Trading
First Appointment 07 Dec 2017
Oldest Company Age 11 yrs
Largest company Eigen Pharmaceuticals Private Limited · ₹11.9 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Dec 20172015₹11.9 Lakh (FY 2020)Active

Board colleagues of Manoj Vaish

NameDINCompanyDesignation
Anoop Vaish07118806Eigen Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Eigen Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Manoj Vaish

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manoj Vaish

Manoj Vaish currently holds 1 directorship: Eigen Pharmaceuticals Private Limited (Director, since 07 Dec 2017, revenue ₹11.9 Lakh (FY 2020)).

Manoj Vaish was first appointed on 07 Dec 2017 as Director at Eigen Pharmaceuticals Private Limited.

The current boards of Manoj Vaish's companies include Anoop Vaish (Eigen Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available